Hepatitis C virus genotype distribution in Egyptian diabetic patients: A preliminary study

Arab Journal of Gastroenterology

Volumn 14, Issue 1, 2013, Pages 14-19

  Saleh, Omayma ^a   Baiomy, Azza A ^a   El desouky, Ayman ^a   Zaghloul, Hosam ^a   El Arman, Mohammad ^a   Dahab, Gamal M ^a   Abdel Rahman, Mohamed S ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Diabetes; Egypt; HCV genotypes; Hepatitis C virus; Insulin resistance

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INSULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; EGYPT; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENOTYPE; GLUCOSE BLOOD LEVEL; HEPATITIS C VIRUS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; C-PEPTIDE; C-REACTIVE PROTEIN; DIABETES MELLITUS; EGYPT; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PLATELET COUNT; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876882879     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2013.01.005     Document Type: Article

References (47)

1. Proceedings of the European Association for the study of the liver international consensus conference on hepatitis C, 26-27 February 1999, Paris, France; 1993. J Hepatol;31(Suppl. 1):1-268.
2. Intitative for vaccine research: hepatitis C [homepage on the Internet], 2008.
3. Wong T., Lee S.S. Hepatitis C: a review for primary care physicians. CMAJ 2006, 174(5):59-649.
4. Strickland G.T., Elhefni H., Salman T., et al. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 2002, 67(4):42-436.
5. Marzouk D., Sass J., Bakr I., et al. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut 2007, 56(8):10-1105.
6. El-Zayadi A., Simmonds P., Dabbous H., et al. Hepatitis C virus genotypes among HCV-chronic liver disease patients in Egypt: a leading trial. J Egypt Public Health Assoc 1994, 69(5-6):327-334.
7. Ray S.C., Arthur R.R., Carella A., et al. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 2000, 182(3):698-707.
8. Payan C., Roudot-Thoraval F., Marcellin P., et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: the GEMHEP GenoCII study. J Viral Hepat 2005, 12(4):405-413.
9. Kamal S.M., Nasser I.A. Hepatitis C genotype 4: what we know and what we don't yet know. Hepatology 2008, 47(4):1371-1383.
10. Fried M.W., Shiffman M.L., Rajender Reddy K., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347(13):975-982.
11. El-Zayadi A.R., Selim O.E., Hamdy H., et al. Association of chronic hepatitis C infection and diabetes mellitus. Trop Gastroenterol 1998, 19(4):141-144.
12. Mehta S.H., Brancati F.L., Strathdee S.A., et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003, 38(1):50-56.
13. Antonelli A., Ferri C., Fallahi P., et al. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology 2004, 43(2):238-240.
14. Antonelli A., Ferri C., Fallahi P., et al. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 2005, 28(10):2548-2550.
15. Chen H.F., Li C.Y., Chen P., et al. Seroprevalence of hepatitis B and C in type 2 diabetic patients. J Chin Med Assoc 2006, 69(4):146-152.
16. Li-Ng M., Tropp S., Danoff A., et al. Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific islanders. Dig Liver Dis 2007, 39(6):549-556.
17. Imazeki F., Yokosuka O., Fukai K., et al. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients. Liver Int 2008, 28(3):355-362.
18. White D.L., Ratziu V., El-Serag H.B. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 2008, 49(5):831-844.
19. Esteban J.I., Sauleda S., Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008, 48(1):148-162.
20. Noto H., Raskin P. Hepatitis C infection and diabetes. J Diabetes Complicat 2006, 20(2):113-120.
21. Lonardo A., Carulli N., Loria P. HCV and diabetes. A two-question-based reappraisal. Dig Liver Dis 2007, 39(8):753-761.
22. Matthews D.R., Hosker J.P., Rudenski A.S. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
23. Bonser A.M., Garcia-Webb P. C-peptide measurement: methods and clinical utility. Crit Rev Clin Lab Sci 1984, 19(4):297-352.
24. Seriolo B., Paolino S., Sulli A., et al. Effects of anti-TNF-α treatment on lipid profile in patients with active rheumatoid arthritis. Ann N Y Acad Sci 2006, 1069:414-419.
25. Chrysanthos N.V., Papatheodoridis G.V., Savvas S., et al. Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis. Eur J Gastroenterol Hepatol 2006, 18(4):389-396.
26. Kau A., Vermehren J., Sarrazin C. Treatment predictors of a sustained virologic response in hepatitis B and C. J Hepatol 2008, 49(4):634-651.
27. Spada E., Mele A., Ciccozzi M., et al. Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Dig Liver Dis 2001, 33(9):778-784.
28. Frank C., Mohamed M.K., Strickland G.T., et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000, 355(9207):887-891.
29. Prati D. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol 2006, 45(4):607-616.
30. Savvas S.P., Koskinas J., Sinani C., et al. Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat 2005, 12(5):551-557.
31. Douglas M.W., George J. Molecular mechanisms of insulin resistance in chronic hepatitis C. World J Gastroenterol 2009, 15(35):4356-4364.
32. Moucari R., Asselah T., Cazals-Hatem D., et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level and liver fibrosis. Gastroenterology 2008, 134(2):416-423.
33. Yoneda M., Saito S., Ikeda T., et al. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients. J Viral Hepat 2007, 14(9):600-607.
34. Hsu C.S., Liu C.J., Liu C.H., et al. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Liver Int 2008, 28(2):271-277.
35. Tanaka N., Nagaya T., Komatsu M., et al. Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase. Liver Int 2008, 28(8):1104-1111.
36. Oliveira B.R., Magalhães O., Furlanetto T.W., et al. Increased insulin resistance and hyperinsulinemia in patients with type 2 diabetes and chronic hepatitis C. Diabetes Res Clin Pract 2008, 79(2):e11-2.
37. Narita R., Abe S., Kihara Y., et al. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J Hepatol 2004, 41(1):132-138.
38. Lecube A., Hernández C., Genescà J., et al. Proinflammatory cytokines, insulin resistance and insulin secretion in chronic hepatitis C patients: a case-control study. Diabetes Care 2006, 29(5):1096-1101.
39. Bonora E., Targher G., Alberiche M., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23(1):57-63.
40. Hui J.M., Sud A., Farrell G.C., et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 2003, 125(6):1695-1704.
41. Negro F. Insulin resistance and HCV: will new knowledge modify clinical management?. J Hepatol 2006, 45(4):514-519.
42. Duseja A., Dhiman R.K., Chawla Y., et al. Insulin resistance is common in patients with predominantly genotype 3 chronic hepatitis C. Dig Dis Sci 2009, 54(8):1778-1782.
43. Petrides A.S., Vogt C., Schulze-Berge D., et al. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994, 19(3):616-627.
44. Merli M., Leonetti F., Riggio O., et al. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology 1999, 30(3):649-654.
45. Picardi A., D'Avola D., Gentilucci U.V., et al. Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes Metab Res Rev 2006, 22(4):274-283.
46. Valenti L., Pulixi E., Fracanzani A.L., et al. TNFα genotype affects TNFα release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis. J Hepatol 2005, 43(6):944-950.
47. Tahan V., Ozaras R., Karaca C., et al. Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?. Hepatogastroenterology 2009, 56(94-95):1425-1428.